Company Announcements

Trading Update

Source: RNS
RNS Number : 1912A
Elixirr International PLC
01 February 2022


("Elixirr", the "Company" or the "Group")

Trading Update


Elixirr International plc (AIM:ELIX), an established, global award-winning challenger consultancy, is pleased to provide an update on trading for the year ended 31 December 2021.


Trading through to the end of 2021 continued to be strong. The Group has continued to support its clients to address their key challenges, with Elixirr's services in relation to digital transformation and innovation in high demand.


Subject to the completion of the audit for the year ended 31 December 2021, the Group expects to record revenue of approximately £50.5m, above the market expectation of £47-50m. Adjusted EBITDA is expected to be approximately £15.5m, above the market expectation of £15.0m and within the range of 30-32% of revenue previously announced.  


As at 31 December 2021, the Group had no debt with cash balances in excess of £31m.


The Group has continued to make good progress on all four of its strategic growth pillars, including:

·      Stretching our current partner team - we achieved organic revenue growth in excess of 30% during 2021, including growth of approximately 100% in our US business

·      Promoting partners from within the firm - we have promoted two experienced principals to partner on 1 January 2022

·      Hiring new partners - six experienced partners joined the business over the course of 2021, with a number of them focused on accelerating the growth of our US business

·      Buying complementary businesses - we completed the acquisition of The Retearn Group Limited in April 2021 and are seeing good traction with selling their procurement and self-funded transformation services into our client base. We remain focused on inorganic growth and are continuing to explore a number of other attractive acquisition opportunities with companies specialising in solving Board room issues, including in the US market which is the fastest growing part of our business.

The Directors expect further organic revenue and Adjusted EBITDA growth in 2022. A more detailed update on expectations for 2022 will be provided by the Directors in conjunction with the release of the full year results for the year ended 31 December 2021 on 4 April 2022.


For further Information please contact:


Elixirr International plc

Stephen Newton, CEO

Graham Busby, CFO





Public and Investor Relations contacts:

Caroline Pitt


finnCap Ltd (Nominated Adviser & Sole Broker)

Christopher Raggett, Kate Bannatyne (Corporate Finance)

Alice Lane, Sunila De Silva (ECM)



            +44 (0)20 7220 0500



About Elixirr International plc

Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.

Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.